My lungs are on fire. My heart is thumping so hard, I can feel my heartbeat in my ears. My breathing is heavy and labored. Pain shoots down my left leg from my sciatic nerve. I stop on the last landing to catch my breath and lean on the post…
Complement inhibitors and plasma exchange therapy are equally safe and effective for atypical hemolytic uremic syndrome (aHUS), but complement inhibitors like Soliris (eculizumab) and Ultomiris (ravulizumab-cwvz) offer an edge in preventing relapses, especially in children, according to a new pooled analysis of real-world data. The analysis reveals…
Becoming educated and informed about aHUS is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnist’s words of wisdom to help you along on your aHUS journey.
There is no cure for aHUS yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
